GlassScriptPhysician profile
Radha Agrawal
NPI 1881629798
$7,643.10
in general payments reported to CMS, 2019-2025
6 companies · $2,267 in 2025
The $2,267 reported for 2025 was more than what 78% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,020 · 2021: $500 · 2022: $2,307 · 2023: $850 · 2024: $699 · 2025: $2,267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,625 · Food and Beverage: $174 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,624.58 |
| Food and Beverage | $173.84 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verathon INC. | $7,374.58 | 2019-2025 | Bronchoscope, Npd Clinical Study |
| Pulmonx Corporation | $146.33 | 2024 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Sanofi-Aventis U.S. LLC | $57.48 | 2022 | |
| Abiomed | $27.51 | 2024 | Impella |
| Genzyme Corporation | $19.82 | 2019 | |
| Insmed, INC. | $17.38 | 2025 | Brinsupri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Radha Agrawal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.